Fluvac Innovator 4

DESCRIPTION Inactivated vaccine for the prevention of equine influenza, equine encephalomyelitis, and tetanus in horses COMPOSITION Inactivated equine influenza virus, Type A2, Kentucky 97 strain; Inactivated equine encephalomyelitis virus (East); Inactivated equine encephalomyelitis virus (West); Tetanus toxoid: Adjuvant: ACTION Immunization against equine influenza, equine encephalomyelitis, and tetanus. The equine influenza component has been updated by our laboratory in accordance with OIE recommendations INDICATIONS For the vaccination of healthy equines to aid in the prevention of equine influenza, equine encephalomyelitis, and tetanus. For equines in transit, vaccination against influenza and encephalomyelitis must comply with current legislation CONTRAINDICATIONS AND WARNINGS Store between 2°C and 7°C in a dark place. Shake well before use. SIDE EFFECTS In case of anaphylactic reactions, administer epinephrine. DOSAGE Administer two doses of 1 mL each by deep intramuscular injection, spaced 4 to 8 weeks apart. Revaccinate annually with one dose. PACKAGING Ready-to-use plastic syringes containing 1 dose and vials containing 10 doses. RESTRICTIONS ON USE Horses intended for human consumption and/or industrial processing must not be vaccinated within 60 days prior to slaughter. ADMINISTRATION : Injectable